During the past decade, Muncie Allergy Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Muncie Allergy Center" are "Hereditary Angioedema (HAE)" (2 trials). Many other conditions were trialed in "Muncie Allergy Center" in a lesser frequency.

Most popular intervention types in "Muncie Allergy Center" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "ecallantide" (2 trials) and "Phosphate Buffer Saline (PBS), pH 7.0" (1 trials). Other intervention names were less common.

The vast majority of trials in "Muncie Allergy Center" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Muncie Allergy Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Muncie Allergy Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Muncie Allergy Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".